First EUA In US For OTC Test To Detect COVID-19, Flu, RSV Granted To Labcorp
Executive Summary
Agency issued an emergency use authorization to Labcorp for its OTC that detects COVID-19, flu and respiratory syncytial virus.
You may also be interested in...
EUA For First At-Home Kit Differentiating COVID-19 From Flu Could Make Difference In Firm’s Survival
The US FDA has authorized sales of the first at-home test that provides results differentiating flu from COVID. Lucira's EUA for the COVID-19 & Flu Test came two days after the company filed for Chapter 11 bankruptcy protection, indicating it would seek a buyer.
EUA For First At-Home Kit Differentiating COVID-19 From Flu Could Be Difference In Firm’s Survival
Sales authorized for first test providing at-home results including differentiating flu from COVID. Lucira gets EUA for its COVID-19 & Flu Test two days after filing for Chapter 11 bankruptcy protection, indicating it would seek buyer.
FDA Suggests Sharing OTC COVID-19 Test Results With NIH Program To Help Health Agencies Plan
FDA releases information about reporting results of OTC at-home COVID-19 antigen tests, as well as recommendations on who should get tested, when and how often.